SC
MRNA icon

Schubert & Co’s Moderna MRNA Stock Holding History

Schubert & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-46
Closed -$7.07K – 947
2023
Q1 		$7.07K Sell
46
-26
-36% -$4.29K 0.01% 324
2022
Q4 		$12.9K Buy
72
+38
+112% +$6.21K 0.01% 177
2022
Q3 		$4K Sell
34
-7
-17% -$1.06K ﹤0.01% 509
2022
Q2 		$6K Buy
41
+28
+215% +$4K 0.01% 300
2022
Q1 		$2K Buy
13
+7
+117% +$1.18K ﹤0.01% 449
2021
Q4 		$2K Buy
+6
New +$1.75K ﹤0.01% 411

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schubert & Co's MRNA Position: Q2 2023 in Review

Schubert & Co sold out of Moderna (MRNA) in Q2 2023, closing a stake of 46 shares — an estimated $7.07K sold.

Schubert & Co first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $12.9K in Q4 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Schubert & Co reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 46 Moderna shares in Q2 2023, an estimated $7.07K.
  • Schubert & Co first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Moderna position peaked at $12.9K in Q4 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.